ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30454-10mM(1mLinDMSO) |
|
71283-80-2 |
Fenoxaprop-P-ethyl
|
0 | C18H16ClNO5 | |
GC30453-20mg |
|
197506-02-8 |
LM-1484
|
0 | C28H24N4O3 | |
GC30453-10mg |
|
197506-02-8 |
LM-1484
|
0 | C28H24N4O3 | |
GC30453-5mg |
|
197506-02-8 |
LM-1484
|
0 | C28H24N4O3 | |
GC30453-1mg |
|
197506-02-8 |
LM-1484
|
0 | C28H24N4O3 | |
GC30452-5mg |
|
118997-30-1 |
Peptide YY (PYY), human
|
0 | C194H295N55O57 | |
GC30452-1mg |
|
118997-30-1 |
Peptide YY (PYY), human
|
0 | C194H295N55O57 | |
GC30452-500μg |
|
118997-30-1 |
Peptide YY (PYY), human
|
0 | C194H295N55O57 | |
GC30451-20mg |
|
145600-69-7 |
AD 0261
|
0 | C27H31F2N3O | |
GC30451-10mg |
|
145600-69-7 |
AD 0261
|
0 | C27H31F2N3O | |
GC30451-5mg |
|
145600-69-7 |
AD 0261
|
0 | C27H31F2N3O | |
GC30451-1mg |
|
145600-69-7 |
AD 0261
|
0 | C27H31F2N3O | |
GC30450-50mg |
|
99700-50-2 |
Tos-Gly-Pro-Arg-ANBA-IPA (tos-GPR-ANBA-IPA)
|
0 | C30H41N9O8S | |
GC30450-10mg |
|
99700-50-2 |
Tos-Gly-Pro-Arg-ANBA-IPA (tos-GPR-ANBA-IPA)
|
0 | C30H41N9O8S | |
GC30450-5mg |
|
99700-50-2 |
Tos-Gly-Pro-Arg-ANBA-IPA (tos-GPR-ANBA-IPA)
|
0 | C30H41N9O8S | |
GC30449-5g |
|
110-17-8 |
Fumaric acid
|
0 | C4H4O4 | |
GC30448-20mg |
|
852-42-6 |
Guaiapate (Klamar)
|
0 | C18H29NO4 | |
GC30448-10mg |
|
852-42-6 |
Guaiapate (Klamar)
|
0 | C18H29NO4 | |
GC30448-5mg |
|
852-42-6 |
Guaiapate (Klamar)
|
0 | C18H29NO4 | |
GC30448-1mg |
|
852-42-6 |
Guaiapate (Klamar)
|
0 | C18H29NO4 | |